US Stock MarketDetailed Quotes
SLRX Salarius Pharmaceuticals
- 2.3000
- +0.2400+11.65%
Close Aug 9 16:00 ET
- 2.2000
- -0.1000-4.35%
Pre 04:31 ET
3.31MMarket Cap-263P/E (TTM)
2.4500High2.0600Low704.89KVolume2.0600Open2.0600Pre Close1.61MTurnover125.70%Turnover RatioLossP/E (Static)1.44MShares7.600052wk High1.40P/B1.29MFloat Cap1.350052wk Low--Dividend TTM560.78KShs Float124099.9504Historical High--Div YieldTTM18.93%Amplitude1.3500Historical Low2.2850Avg Price1Lot Size
Salarius Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 75.72%-1.07M | 57.28%-1.35M | 26.99%-12.85M | 67.94%-1.51M | 34.70%-3.75M | -22.01%-4.42M | 9.98%-3.17M | -72.50%-17.6M | -73.26%-4.71M | -262.90%-5.74M |
| Net income from continuing operations | 63.26%-1.42M | 67.88%-1.72M | 60.32%-12.54M | 86.16%-881.8K | 83.05%-2.44M | 17.82%-3.88M | 12.58%-5.34M | -147.55%-31.61M | -55.20%-6.37M | -285.58%-14.41M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 67.66%-14.45K | ---- | ---- |
| Depreciation and amortization | -33.73%1.11K | -33.67%1.11K | 50.53%10.05K | -33.79%1.11K | 236.21%5.61K | 214.55%1.67K | -65.21%1.67K | -65.19%6.68K | -65.20%1.67K | -65.22%1.67K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.99M | --0 | --0 |
| Change In working capital | 140.04%265.97K | -85.62%282.72K | -140.86%-968.33K | -146.96%-715.91K | -361.17%-1.55M | -173.75%-664.27K | 597.78%1.97M | 16.48%2.37M | 19.74%1.52M | -116.61%-337.08K |
| -Change in receivables | --0 | --0 | --1.48M | --0 | --0 | --0 | --1.48M | --0 | --0 | --0 |
| -Change in prepaid assets | -14.14%228.35K | -37.64%175.05K | 298.82%807.77K | -61.90%135.92K | 116.40%125.17K | -13.88%265.95K | -6.53%280.73K | 387.41%202.54K | 37.56%356.73K | -2.13%-763.36K |
| -Change in payables and accrued expense | 104.04%37.62K | -47.51%107.67K | -250.26%-3.26M | -172.95%-851.84K | -494.02%-1.68M | -257.18%-930.22K | 1,206.11%205.11K | 1,642.22%2.17M | 117.01%1.17M | 529.35%426.29K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 75.72%-1.07M | 57.28%-1.35M | 26.99%-12.85M | 67.94%-1.51M | 34.70%-3.75M | -22.01%-4.42M | 9.98%-3.17M | -72.50%-17.6M | -73.26%-4.71M | -262.90%-5.74M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -1.5M | 0 | 0 | |||||
| Net intangibles purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---1.5M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---1.5M | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -100.42%-28.19K | -151.31%-172.75K | 234.09%6.64M | -16,945,000.00%-169.45K | -147.19%-211.83K | 222.43%6.68M | 336.68K | -92.98%1.99M | -100.00%1 | -121.09%-85.7K |
| Net issuance payments of debt | ---116.86K | ---172.79K | ---280.92K | ---169.45K | ---111.47K | --0 | --0 | --0 | --0 | ---- |
| Net common stock issuance | -98.67%88.67K | -99.99%38 | 248.22%6.92M | -200.00%-1 | -17.11%-100.36K | 222.43%6.68M | --336.68K | -92.72%1.99M | -100.00%1 | -121.09%-85.7K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -100.42%-28.19K | -151.31%-172.75K | 234.09%6.64M | -16,945,000.00%-169.45K | -147.19%-211.83K | 222.43%6.68M | --336.68K | -92.98%1.99M | -100.00%1 | -121.09%-85.7K |
| Net cash flow | ||||||||||
| Beginning cash position | -52.84%4.37M | -51.27%5.9M | -58.56%12.11M | -54.93%7.58M | -49.04%11.54M | -61.67%9.27M | -58.56%12.11M | 162.75%29.21M | -47.28%16.82M | -31.54%22.65M |
| Current changes in cash | -148.52%-1.1M | 46.11%-1.53M | 63.72%-6.21M | 64.35%-1.68M | 32.02%-3.96M | 246.63%2.27M | 43.58%-2.83M | -194.54%-17.11M | -75.28%-4.71M | -395.62%-5.83M |
| End cash Position | -71.64%3.27M | -52.84%4.37M | -51.27%5.9M | -51.27%5.9M | -54.93%7.58M | -49.04%11.54M | -61.67%9.27M | -58.56%12.11M | -58.56%12.11M | -47.28%16.82M |
| Free cash flow | 75.72%-1.07M | 57.28%-1.35M | 32.73%-12.85M | 67.94%-1.51M | 34.70%-3.75M | -22.01%-4.42M | 36.87%-3.17M | -87.21%-19.1M | -73.26%-4.71M | -262.90%-5.74M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
